Kristin C. Carlsson Petri

Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years

Thomas Danne, Torben Biester, Kerstin Kapitzke et al. · The Journal of Pediatrics · 2016 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics

Lucy D. Mastrandrea, Louise Witten, Kristin C. Carlsson Petri et al. · Pediatric Obesity · 2019 · 87 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis

Rune Viig Overgaard, Kristin C. Carlsson Petri, Lisbeth V. Jacobsen et al. · Clinical Pharmacokinetics · 2016 · 60 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Exposure‐response analysis for evaluation of semaglutide dose levels in type 2 diabetes

Kristin C. Carlsson Petri, Steen H. Ingwersen, Anne Flint et al. · Diabetes Obesity and Metabolism · 2018 · 48 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis

Kristin C. Carlsson Petri, Steen H. Ingwersen, Anne Flint et al. · Diabetes Therapy · 2018 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16